Study to Evaulate the Kappa Opioid Receptor as a Target for the Treatment of Mood and Anxiety Spectrum Disorders by Evaluating Whether LY2456302 Engages Reward-related Neural Circuitry.
Clinical Trial Grant
Awarded By
National Institutes of Health
Start Date
August 29, 2013
End Date
December 31, 2017
Awarded By
National Institutes of Health
Start Date
August 29, 2013
End Date
December 31, 2017